<TABLE> <S> <C>

         <ARTICLE>                     5
         <LEGEND>         
     Financial  Data  Schedule  for 10KSB -  04-30-97  for  American  Bio Medica
Corporation
         </LEGEND>
       
         <S>                                             <C>
         <PERIOD-TYPE>                                   12-MOS
         <FISCAL-YEAR-END>                               APR-30-1997
         <PERIOD-START>                                  MAY-1-1996
         <PERIOD-END>                                    APR-30-1997
         <CASH>                                            1,762,506                                             
         <SECURITIES>                                      1,053,000                                        
         <RECEIVABLES>                                       337,759         
         <ALLOWANCES>                                              0                                        
         <INVENTORY>                                         668,723                                         
         <CURRENT-ASSETS>                                  3,928,663                                    
         <PP&E>                                              133,368                                              
         <DEPRECIATION>                                      (22,534)                                      
         <TOTAL-ASSETS>                                    4,106,750                                                         
         <CURRENT-LIABILITIES>                               380,155                                        
         <BONDS>                                                   0                                             
         <PREFERRED-MANDATORY>                                     0 
         <PREFERRED>                                               1                                         
         <COMMON>                                          6,633,587                                          
         <OTHER-SE>                                       (2,906,992) 
         <TOTAL-LIABILITY-AND-EQUITY>                      4,106,750                        
         <SALES>                                             610,876 
         <TOTAL-REVENUES>                                    610,876 
         <CGS>                                               259,862
         <TOTAL-COSTS>                                     1,039,015            
         <OTHER-EXPENSES>                                    182,680              
         <LOSS-PROVISION>                                   (505,321)            
         <INTEREST-EXPENSE>                                        0                                 
         <INCOME-PRETAX>                                    (505,321)                              
         <INCOME-TAX>                                              0   
         <INCOME-CONTINUING>                                (505,321)
         <DISCONTINUED>                                            0    
         <EXTRAORDINARY>                                           0   
         <CHANGES>                                                 0      
         <NET-INCOME>                                       (505,321)
         <EPS-PRIMARY>                                          (.04)
         <EPS-DILUTED>                                          (.04)  
        


</TABLE>